sulfinpyrazone has been researched along with Arrhythmias, Cardiac in 15 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Single intravenous injection of adrenochrome (10 to 50 mg/kg body weight), an oxidation product of catecholamines, has been shown to induce arrhythmias and cause death in anesthetized rats in a dose-dependent manner." | 7.66 | Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. ( Beamish, RE; Dhalla, NS; Dhillon, KS; Singal, PK, 1981) |
| " A recent double-blind multicenter trial ("Anturane Reinfarction Trial") showed that the incidence of sudden cardiac death was reduced in Sulfinpyrazone-treated patients after acute myocardial infarction compared with the placebo group, although the rate of reinfarctions was not diminished." | 7.66 | [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)]. ( Bender, F; Dorsel, T; Gülker, H; Heuer, H; Kristek, J; Pierchalla, P; Thale, J, 1980) |
| "Single intravenous injection of adrenochrome (10 to 50 mg/kg body weight), an oxidation product of catecholamines, has been shown to induce arrhythmias and cause death in anesthetized rats in a dose-dependent manner." | 3.66 | Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias. ( Beamish, RE; Dhalla, NS; Dhillon, KS; Singal, PK, 1981) |
| " A recent double-blind multicenter trial ("Anturane Reinfarction Trial") showed that the incidence of sudden cardiac death was reduced in Sulfinpyrazone-treated patients after acute myocardial infarction compared with the placebo group, although the rate of reinfarctions was not diminished." | 3.66 | [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)]. ( Bender, F; Dorsel, T; Gülker, H; Heuer, H; Kristek, J; Pierchalla, P; Thale, J, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boissel, JP | 1 |
| Leizorovicz, A | 1 |
| Faucomprez, C | 1 |
| Roos, JC | 1 |
| Dunning, AJ | 1 |
| Avellone, G | 1 |
| Mandalà, V | 1 |
| Novo, S | 1 |
| Pinto, A | 1 |
| Riolo, FP | 1 |
| Davì, G | 1 |
| Raneli, G | 1 |
| Easton, JD | 1 |
| Hart, RG | 1 |
| Sherman, DG | 1 |
| Kaste, M | 1 |
| Bolte, HD | 1 |
| Wilcox, RG | 1 |
| Richardson, D | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Banks, DC | 1 |
| Beamish, RE | 1 |
| Dhillon, KS | 1 |
| Singal, PK | 1 |
| Dhalla, NS | 1 |
| Rabkin, SW | 1 |
| Ohmae, M | 1 |
| Gülker, H | 1 |
| Bender, F | 1 |
| Thale, J | 1 |
| Heuer, H | 1 |
| Kristek, J | 1 |
| Dorsel, T | 1 |
| Pierchalla, P | 1 |
| Haft, JI | 1 |
| Watt, M | 1 |
| Kane, SH | 1 |
| Bellows, JG | 1 |
| Jouve, R | 1 |
| Larrue, J | 1 |
3 reviews available for sulfinpyrazone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagu | 1980 |
[Platelet anti-aggregant drugs and ischemic cardiopathy: evaluation of the effect on platelet aggregation and on antithrombin III].
Topics: Adult; Anticoagulants; Antithrombin III; Arrhythmias, Cardiac; Clofibrate; Dipyridamole; Female; Hum | 1981 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
6 trials available for sulfinpyrazone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagu | 1980 |
Sulfinpyrazone: an antiarrhythmic drug?
Topics: Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Clinical Trials as Topic; Double-Blind Method; Ele | 1982 |
Anturan: new use for an old drug.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Humans; Myocardial Infarction; Sulfin | 1980 |
Sulphinpyrazone in acute myocardial infarction: studies on cardiac rhythm and renal function.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Creatinine; Double-Blind Method; Female; Humans; Mal | 1980 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Co | 1979 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase I | 1985 |
8 other studies available for sulfinpyrazone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management.
Topics: Anticoagulants; Arrhythmias, Cardiac; Aspirin; Brain Ischemia; Carotid Artery Thrombosis; Cerebral A | 1983 |
[Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Topics: Arrhythmias, Cardiac; Aspirin; Death, Sudden; Humans; Myocardial Infarction; Platelet Aggregation; S | 1980 |
Protective effect of sulfinpyrazone against catecholamine metabolite adrenochrome-induced arrhythmias.
Topics: Adrenochrome; Animals; Arrhythmias, Cardiac; Blood Pressure; Catecholamines; Dose-Response Relations | 1981 |
Effect of sulfinpyrazone on adriamycin induced acute cardiotoxic arrhythmias in rabbits.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Doxorubicin; Electrocardiography; Hemodynamics; Rabbi | 1980 |
[Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
Topics: Animals; Arrhythmias, Cardiac; Dogs; Myocardial Infarction; Sulfinpyrazone; Ventricular Fibrillation | 1980 |
Myocardial re-infarction and sulphinpyrazone.
Topics: Arrhythmias, Cardiac; Humans; Myocardial Infarction; Sulfinpyrazone | 1978 |
Sulphinpyrazone after myocardial infarction.
Topics: Arrhythmias, Cardiac; Humans; Myocardial Infarction; Sulfinpyrazone | 1978 |
Cardiac dysrhythmias.
Topics: Arrhythmias, Cardiac; Disopyramide; Humans; Quinidine; Sulfinpyrazone | 1978 |